Literature DB >> 9923444

Late expression of red cell membrane protein 4.2 in normal human erythroid maturation with seven isoforms of the protein 4.2 gene.

H Wada1, A Kanzaki, A Yawata, T Inoue, M Kaku, M Takezono, T Sugihara, O Yamada, Y Yawata.   

Abstract

The expression of protein 4.2 in normal human erythroid cells was studied utilizing erythroblasts from bone marrow and erythroid cells cultured by the two-phase liquid culture method from burst-forming unit erythroid (BFU-E) in peripheral blood. As opposed to spectrin, which was expressed in erythroid progenitors or very early erythroblasts, protein 4.2 was first detected in late erythroblasts with a morphology nearly identical to orthochromatic erythroblasts. Among the various major membrane proteins, the expression of protein 4.2 was the latest. At the gene level, protein 4.2 gene mRNA was expressed in early erythroblasts. During normal erythroid maturation, the expression of seven different protein 4.2 gene products was observed by Southern blot analysis. These seven gene products appeared to be derived from protein 4.2 gene in the presence or absence of skipping of the 90 bp in exon 1, exon 3, and/or exon 5, as judged by deduction from the protein 4.2 sequence. Therefore, it can be speculated that protein 4.2 is expressed after the cytoskeletal network has been constructed and assembled with integral proteins in the membrane lipid bilayer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9923444     DOI: 10.1016/s0301-472x(98)00014-9

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  6 in total

1.  Immunohistochemical identification of erythroid precursors in paraffin embedded bone marrow sections: spectrin is a superior marker to glycophorin.

Authors:  Y Sadahira; A Kanzaki; H Wada; Y Yawata
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

2.  Investigating the key membrane protein changes during in vitro erythropoiesis of protein 4.2 (-) cells (mutations Chartres 1 and 2).

Authors:  Emile van den Akker; Timothy J Satchwell; Stephanie Pellegrin; Joanna F Flatt; Michel Maigre; Geoff Daniels; Jean Delaunay; Lesley J Bruce; Ashley M Toye
Journal:  Haematologica       Date:  2010-02-23       Impact factor: 9.941

3.  DNA methylation in promoter regions of red cell membrane protein genes in healthy individuals and patients with hereditary membrane disorders.

Authors:  Ralph Remus; Akio Kanzaki; Ayumi Yawata; Hidekazu Nakanishi; Hideho Wada; Takashi Sugihara; Michael Zeschnigk; Ines Zuther; Birgit Schmitz; Frauke Naumann; Walter Doerfler; Yoshihito Yawata
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

4.  Ankyrin gene mutations in japanese patients with hereditary spherocytosis.

Authors:  H Nakanishi; A Kanzaki; A Yawata; O Yamada; Y Yawata
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

5.  Relationships between DNA methylation and expression in erythrocyte membrane protein (band 3, protein 4.2, and beta-spectrin) genes during human erythroid development and differentiation.

Authors:  Ralph Remus; Akio Kanzaki; Ayumi Yawata; Hideho Wada; Hidekazu Nakanishi; Takashi Sugihara; Michael Zeschnigk; Ines Zuther; Birgit Schmitz; Frauke Naumann; Walter Doerfler; Yoshihito Yawata
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

6.  The sorting of blood group active proteins during enucleation.

Authors:  Timothy J Satchwell; Amanda J Bell; Ashley M Toye
Journal:  ISBT Sci Ser       Date:  2015-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.